
Etonip 600mg Tablet ER
Marketer
Nova Indus Pharmaceuticals
Salt Composition
Etodolac (600mg)
Overview Etonip 600mg Tablet ER
Extended-release Etonip 600mg tablets offer pain relief and reduce inflammation. This medication is indicated for conditions such as rheumatoid and osteoarthritis, as well as acute pain episodes. Dosage and treatment duration should strictly adhere to your physician's instructions. To minimize gastrointestinal discomfort, take this medication with food or milk. Prior heart conditions or stroke history must be disclosed to your doctor. Commonly reported side effects include nausea, vomiting, indigestion, and abdominal pain. Dizziness, drowsiness, and blurred vision are also possible. For extended treatment, your doctor may monitor kidney and liver function, along with blood counts. Prolonged use carries a risk of complications including gastric bleeding and renal impairment.
Uses of Etonip 600mg Tablet ER
Analgesia
Major Benefits of Etonip 600mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Etonip 600mg Extended-Release tablets should be administered with a meal.
Common Side effects of Etonip 600mg Tablet ER:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Dizziness
- Drowsiness
How to use Etonip 600mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Etonip 600mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
How Etonip 600mg Tablet ER works:
Etonip 600mg Extended-Release Tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Etonip 600mg extended-release tablets.
PregnancyCONSULT YOUR DOCTOR
The extended-release Etonip 600mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release etonip 600mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Etonip 600mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Extended-release Etonip 600mg tablets appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, professional medical counsel is recommended. Routine monitoring of renal function is prudent during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Etonip 600mg Extended-Release Tablets in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Etonip 600mg Tablet ER :
Should you forget to take your Etonip 600mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Etonip 600mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Indole Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
